Lantern Pharma Inc.
NASDAQ:LTRN
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.58
5.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
LTRN
stock under the Base Case scenario is
2.148
USD.
Compared to the current market price of 3.538 USD,
Lantern Pharma Inc.
is
Overvalued by 39%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Lantern Pharma Inc..
Fundamental Analysis
LTRN Profitability Score
Profitability Due Diligence
Score
LTRN Solvency Score
Solvency Due Diligence
Score
Select up to 3 indicators:
Select up to 3 indicators:
Balance Sheet Decomposition
Lantern Pharma Inc.
Lantern Pharma Inc.
Free Cash Flow Analysis
Lantern Pharma Inc.
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Lantern Pharma Inc.
Wall St
Price Targets
LTRN Price Targets Summary
Lantern Pharma Inc.
According to Wall Street analysts, the average 1-year price target for
LTRN
is 20.4 USD
with a low forecast of 15.15 USD and a high forecast of 26.25 USD.
Dividends
Current shareholder yield for
LTRN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LTRN
stock under the Base Case scenario is
2.148
USD.
Compared to the current market price of 3.538 USD,
Lantern Pharma Inc.
is
Overvalued by 39%.